Cowen Downgrades Merrimack Pharmaceuticals (MACK) to Market Perform

August 5, 2016 9:22 AM EDT
Get Alerts MACK Hot Sheet
Price: $5.27 +3.33%

Rating Summary:
    5 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade MACK Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Cowen downgraded Merrimack Pharmaceuticals (NASDAQ: MACK) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Merrimack Pharmaceuticals click here. For more ratings news on Merrimack Pharmaceuticals click here.

Shares of Merrimack Pharmaceuticals closed at $5.92 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Cowen & Co

Add Your Comment